Texas Instruments Stock Is Running On A Bold Promise

The chipmaker signaled a major turn in its business, and the market bought it. Now comes the hard part: proving the rally can last.

When Texas Instruments (TXN) updated its forward guidance on Apr 22, 2026, it went far beyond a simple nudge, pointing to earnings per share a stunning 41% above the prior period’s target. The market, starved for a clear signal, listened. The stock has climbed +25% since that day, rewarding investors who bet the cyclical turn was finally here. But after a run like that, you have to ask: is the market getting ahead of itself, or is this just the start of a much bigger recovery?

What’s Fueling This Business Acceleration?

This growth stems from a broad-based surge. The company’s latest results show a business hitting its stride, with revenue growth over the last twelve months at 14.9%, a sharp reversal from its 3-year average decline of -1.1%. The engine rooms are its industrial and data center end markets. Management noted that industrial sales jumped more than 30% year-on-year, while the data center business exploded, growing about 90% in the same period. This is the kind of fundamental firepower that gets investors to pay attention and pay up.

But Is This Another “Head Fake”?

Here’s the tension. Anyone watching the semiconductor space remembers the false start, which the CEO himself acknowledged could be seen as a “a head fake, a false start or whatever.” The biggest question, he admitted, is whether this new growth is sustainable. The bull case, however, has a compelling counterargument. Even after that powerful quarter, management pointed out that its industrial business was still running 15% lower than its peak back in 2022. If this is a true cyclical recovery, that suggests there is still a lot of room to grow before the cycle even gets back to its old highs.

What’s The Catch For Owning It Here?

This ride isn’t likely to be a smooth one. The options market is pricing in an unusual amount of turbulence for the stock, with an implied volatility of 60%. That figure sits in the 100th percentile of its one-year range, meaning options traders are betting on a much larger-than-normal price swing around the next earnings report. The higher bar has been set, and now the company has to clear it, quarter after quarter. For investors, that means the reward for being right could be significant, but the price of being wrong is just as steep.

After false starts, is this the durable recovery investors have been waiting for?

Where Else Is This Setup Showing Up Right Now?

Quite a few. Linde (LIN), Eli Lilly (LLY), and Merck (MRK) are flashing the classic version of it today, a raised outlook with the share price already climbing to match. Our Guidance Momentum screen tracks the full list of S&P 500 names where a higher forecast meets real price momentum, so you can see which ones may still be early in their run.

And if it is exposure to semiconductors as a whole you want rather than any one riser, a semiconductor ETF like SMH covers that single sector.

A Raised Outlook Is Still One Company’s Outlook

Momentum in the numbers is a genuine positive – but it is still one company’s forecast, and forecasts get cut as fast as they get raised. When a single name is a large share of your wealth, a guide-down is not a headline, it is real money, and trimming to protect it hands a chunk to the IRS. There is a way to cap the downside and diversify out without the tax hit.